Vanguard Group Inc Aldeyra Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,591,869 shares of ALDX stock, worth $18.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,591,869
Previous 3,501,593 2.58%
Holding current value
$18.2 Million
Previous $13.4 Million 38.46%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$4.0 - $5.89 $361,104 - $531,725
90,276 Added 2.58%
3,591,869 $18.6 Million
Q2 2025

Aug 11, 2025
SELL
$1.42 - $5.48 $307,323 - $1.19 Million
-216,425 Reduced 5.82%
3,501,593 $13.4 Million
Q1 2025

May 09, 2025
SELL
$4.7 - $6.98 $182,219 - $270,614
-38,770 Reduced 1.03%
3,718,018 $21.4 Million
Q4 2024

Feb 11, 2025
SELL
$4.21 - $5.9 $16,128 - $22,602
-3,831 Reduced 0.1%
3,756,788 $18.7 Million
Q3 2024

Nov 13, 2024
BUY
$3.19 - $6.32 $58,163 - $115,232
18,233 Added 0.49%
3,760,619 $20.3 Million
Q2 2024

Aug 13, 2024
SELL
$3.25 - $4.72 $411,752 - $597,990
-126,693 Reduced 3.27%
3,742,386 $12.4 Million
Q1 2024

May 10, 2024
SELL
$2.77 - $4.22 $162,094 - $246,945
-58,518 Reduced 1.49%
3,869,079 $12.7 Million
Q4 2023

Feb 14, 2024
BUY
$1.47 - $6.06 $1.09 Million - $4.49 Million
740,177 Added 23.22%
3,927,597 $13.8 Million
Q3 2023

Nov 14, 2023
BUY
$6.11 - $8.16 $44,150 - $58,964
7,226 Added 0.23%
3,187,420 $21.3 Million
Q2 2023

Aug 14, 2023
BUY
$7.11 - $11.89 $4.84 Million - $8.1 Million
681,033 Added 27.25%
3,180,194 $26.7 Million
Q1 2023

May 15, 2023
BUY
$5.77 - $9.93 $39,766 - $68,437
6,892 Added 0.28%
2,499,161 $24.8 Million
Q4 2022

Feb 10, 2023
SELL
$5.08 - $7.09 $119,964 - $167,430
-23,615 Reduced 0.94%
2,492,269 $17.3 Million
Q3 2022

Nov 14, 2022
BUY
$3.8 - $7.74 $300,678 - $612,435
79,126 Added 3.25%
2,515,884 $13.4 Million
Q2 2022

Aug 12, 2022
SELL
$2.43 - $4.85 $1.28 Million - $2.55 Million
-524,877 Reduced 17.72%
2,436,758 $9.72 Million
Q1 2022

May 13, 2022
BUY
$3.25 - $5.17 $480,060 - $763,665
147,711 Added 5.25%
2,961,635 $13.2 Million
Q4 2021

Feb 14, 2022
BUY
$3.5 - $9.63 $302,848 - $833,264
86,528 Added 3.17%
2,813,924 $11.3 Million
Q3 2021

Nov 12, 2021
BUY
$7.94 - $11.31 $245,711 - $349,999
30,946 Added 1.15%
2,727,396 $23.9 Million
Q2 2021

Aug 13, 2021
BUY
$10.44 - $14.85 $28.2 Million - $40 Million
2,696,450 New
2,696,450 $30.6 Million

Others Institutions Holding ALDX

# of Institutions
143
Shares Held
39.9M
Call Options Held
344K
Put Options Held
71.7K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $296M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email